$LAES

O'Hara John Charles sold $16K of LAES

O'Hara John Charles (Chief Financial Officer) sold 4,689 shares of SEALSQ Corp (LAES) at $3.50 on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'Hara John Charles
Published May 29, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LAES
Neutral
medium confidence
Mentioned
$LAES
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LAESNeutralLow
01

Why it matters

Because the sale is pre-arranged, it is less likely to reflect new negative information; traders may still monitor for follow-on insider activity or other catalysts.

02

Market read

Provides a fresh, timestamped insider-selling datapoint for LAES, but with reduced bearish interpretation due to 10b5-1 pre-arrangement.

03

What to watch

The article does not state whether other insiders bought/sold, nor does it quantify total insider ownership changes beyond the post-transaction holdings.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-29 after the sale executed on 2026-05-27

Background

The article is an SEC Form 4 insider transaction disclosure for SEALSQ Corp (LAES), showing an officer/director sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$LAESNeutralMedium confidence
Context

SEALSQ CFO John Charles sold 4,689 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other negative catalysts.

Evidence & confidence

The filing provides a concrete datapoint (sale size/price) but does not indicate new operational or financial developments, and the sale is explicitly under a pre-arranged plan.

Market effects

Minimal; this is company-specific insider activity without sector-wide implications in the article.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can be routine liquidity events; the disclosure may be misread as bearish without corroborating fundamentals.

Key entities

  • SEALSQ Corp

    Company whose shares were sold by an officer under a 10b5-1 plan.

  • O'Hara John Charles

    Chief Financial Officer and officer/director who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LAESMed

SEALSQ reports 120% revenue growth in first half of 2026

SEALSQ (NASDAQ:LAES) reported preliminary unaudited revenue of about $11M for 1H 2026 versus $5M in 1H 2025, with Q2 revenue around $7M versus $4M in Q1 2026. Cash and short-term investments were about $485M after a $125M registered direct offering. It reaffirmed 2026 revenue guidance of 50% to 100% growth on $18.3M FY2025. It also updated PQC certification timelines and signed deals with GlobalFoundries and Quobly.

$LAESMed

SEALSQ Signs $5M Deal to Secure Quobly Quantum Platform

SEALSQ Corp (NASDAQ: LAES) issued a CEO letter citing preliminary unaudited H1 2026 revenue of about $11M, up from $5M in H1 2025, and Q2 revenue around $7M versus $4M in Q1. As of June 30, 2026 it reported about $485M cash and short-term investments and reaffirmed 2026 revenue guidance of $27M to $36M. The company also cited a $5M commercial agreement with Quobly and certification progress for QS7001 and QVault TPM.

$LAESMed

SEALSQ Issues CEO Letter to Shareholders

SEALSQ (NASDAQ: LAES) issued a CEO shareholder letter saying first-half 2026 preliminary revenue rose to about $11 million from $5 million in 1H 2025, with Q2 2026 revenue about $7 million. Cash and short-term investments were about $485 million as of June 30, 2026. The company reaffirmed 2026 guidance of 50% to 100% revenue growth (about $27 million to $36 million) and cited certification progress and new partnerships, including a $5 million Quobly agreement and a GlobalFoundries MOU.

$LAESMed

SEALSQ Connects Chipmaking to Two Quantum Processor Designs

SEALSQ (NASDAQ: LAES) said its SEALQuantum.com “Sovereign Quantum Vertical Stack” is integrating partners across secure semiconductors, post-quantum cryptography, identity, AI and satellite infrastructure. The company plans a second phase of a $200 million internal quantum initiative starting September 2026, after deploying over $65 million so far and earmarking $100 million through end-2027.

Med

SEALSQ Completes $200M Fund Deployment with Miraex Quantum Buy

SEALSQ Corp said it completed its June 2, 2026 acquisition of Miraex SA, using capital from a newly formed $200 million Quantum Fund. SEALSQ plans to commercialize Miraex’s thin-film lithium tantalate photonic integrated circuit technology for converting quantum signals between microwave and optical frequencies, targeting quantum computing, networking, sensing, and secure satellite communications.